Jillian L. Rosengard, MD, is an attending physician and Associate Professor of Neurology at Montefiore Einstein. She specializes in the diagnosis and management of seizures and epilepsy. She has a particular interest in treating patients with intractable epilepsy and caring for women with epilepsy during their pregnancies, as well as medical education.

After obtaining her Bachelor of Arts at Harvard in 2008, Dr. Rosengard earned her Doctor of Medicine at Mount Sinai School of Medicine in 2012. She completed an internship in internal medicine at New York University Langone Medical Center in 2013 before completing her residency in neurology at Mount Sinai Medical Center in 2016, where she served as Chief Resident. Dr. Rosengard then completed a fellowship in clinical neurophysiology at Einstein in 2017.

Dr. Rosengard's research focuses on the impact of Covid-19 on patients with epilepsy as well as seizure prediction. She also participates in drug trials for new anti-seizure medications through Montefiore’s Clinical Research Center. She has been Principal Investigator and Co-Principal Investigator on several research projects, and her work has been published in numerous peer-reviewed journals and textbooks. Dr. Rosengard has given national presentations and has been a reviewer for scientific journals including Neurology, Epilepsy & Behavior and the Journal of the Neurological Sciences.

Dr. Rosengard is board certified in Neurology and Epilepsy by the American Board of Psychiatry and Neurology. She is a member of the American Academy of Neurology and the American Epilepsy Society. In 2023, Dr. Rosengard was elected into the Leo M. Davidoff Society for outstanding achievement in the teaching of medical students, and she has been named a New York Super Doctors Rising Star for several years.